Haemonetics Corporation (HAE)

Blood management device maker, FTE count. Read November 9, 2026 from the annual report for the period ending March 28, 2026, filed May 20, 2026. Ranked 117 of the 145 Healthcare companies read so far, by the share within reach now.

The filing states the full-time equivalent of 3,009 persons at March 28, 2026, 78% in North America, and describes one medical device business across plasma, blood center and hospital products, so the whole workforce is read at medical equipment manufacturing.

The figures on this page come from the company's own annual report and from BLS staffing patterns for its industries, never from a roster. They are estimates with a stated method. Nothing here says what the company will do: within reach is not a forecast of jobs lost or of savings.

What follows from the reading

Share of working time within reach of AI, on the long-run pace at four in five: 29% now, 36% at the end of 2027, 38% at the end of 2028, 38% at the end of 2030. By the patterns, the work is about 38% desk work, 16% people work and 46% body work. These are the site's industry estimates weighted by the shares below: estimates with a stated method and range, not a forecast of what the company will do. By the same patterns, at the end of 2028 about 57% of the working time stays with people (conversation, in-person and hands-on work), 36% becomes checking a model's work and 6% could be handed over with lighter checks, from the industries' own figures, not the company's roles.

Headcount

3,009 employees as of March 28, 2026 (full-time equivalent). Not stated as a country figure: approximately 78% of employees are in North America and 22% across 17 other countries.

The filing: “As of March 28, 2026, we employed the full-time equivalent of 3,009 persons.”

The workforce as industry patterns

What the filing says about the workforce: The full-time equivalent of 3,009 persons at March 28, 2026; about 78% in North America and 22% across 17 other countries; nearly 90% took the fiscal 2025 engagement survey; a hybrid work offering for the U.S. corporate offices.

Companies read with the same leading pattern

Other companies whose largest staffing pattern is also Medical Equipment and Supplies Manufacturing, largest first, each read from its own annual report. Within reach now and at the end of 2028, long-run pace, four in five. Now is projected from METR's April 2026 measurement and Epoch's November 2026 index.

• Abbott Laboratories (ABT, 115,000 employees)28% now, 37% by 2028
• Becton, Dickinson and Company (BDX, 72,000 employees)29% now, 38% by 2028
• Boston Scientific Corporation (BSX, 59,000 employees)32% now, 44% by 2028
• Stryker Corporation (SYK, 56,000 employees)30% now, 41% by 2028
• Baxter International Inc. (BAX, 37,500 employees)30% now, 39% by 2028
• Align Technology, Inc. (ALGN, 20,290 employees)29% now, 38% by 2028
• Solventum Corporation (SOLV, 20,000 employees)33% now, 45% by 2028
• STERIS plc (STE, 17,937 employees)33% now, 41% by 2028

What the filing says about AI

4 sentences in the filing name AI. The filing names AI in its risk factors: its product development depends in part on effectively using artificial intelligence and machine learning capabilities, and AI brings opportunities and risks in its own, its suppliers' and its customers' operations and in cybersecurity.

• “The results of our product development efforts may be affected by a number of factors, including our ability to anticipate customer needs, innovate and develop new products and technologies, effectively use artificial intelligence ("AI") and machine learning capabilities, successfully complete clinical trials, obtain regulatory approvals in the United States and abroad, manufacture products in...”
• “This includes opportunities as well as risks associated with the integration of AI into our or our suppliers' or customers' operations.”
• “While AI presents significant opportunities for innovation and efficiency, it could also introduce new risks in managing information systems and in the cybersecurity threat landscape.”
• “Emerging technologies such as generative AI may be used by malicious actors to create more targeted phishing narratives or otherwise strengthen social engineering capabilities, which may increase our threat landscape.”

Its annual reports, year by year

Sentences naming AI in each annual report, counted by one rule, beside the median report in the Index that year. Each count links its filing. Every company, by year and sector

• Fiscal 20210median 0
• Fiscal 20220median 0
• Fiscal 20232median 1
• Fiscal 20244median 4
• Fiscal 20254median 10

Headcount by filing year

As reported in each year's annual report, with the filing. A year marked not read had no figure the reading could take from the report's text.

Limits of this reading

• The headcount is a full-time equivalent figure (rule 2).
• The U.S. share is not stated; the filing gives North America at 78%.
• No count by function or segment, so the single pattern is by description (c).

Source: the company's annual report on EDGAR, accession 0000313143-26-000050, the filing. Read by Claude Fable 5.1 under rubric version 1, by the method. A company can write to info@stratussc.com to have its reading checked against its filing.